This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Cardene

Roche Holding AG

Drug Names(s): Nicardipine hydrochloride

Description: Cardene inhibits the transmembrane influx of calcium ions into cardiac muscle and smooth muscle without chaning serum calcium concentrations. The contractile process of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels. Cardene's effects apply more to vascular smooth muscle than cardiac muscle.

Deal Structure: All historical revenue for Cardene is recorded under Cardene IV.


Cardene News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug